Methocarbamol Tablet, Film Coated
Product Images NDC 76385-124

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Methocarbamol (NDC 76385-124). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Unichem Pharmaceuticals (usa), Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

500 mg 100 Count Bottle Label (500mg Container)

500 mg 100 Count Bottle Label (500mg Container)
This is a description of medication containing methocarbamol in tablet form. Each tablet contains 500 mg of the active ingredient. The recommended dosage is two to four tablets taken four times a day as per the accompanying literature. The tablets should be stored in a container at a controlled temperature between 20°C and 25°C. The medication has been distributed by Bayshore Pharmaceuticals LLC based in Short Hills, NJ. The label shows that the medication is manufactured by Beximco Pharmaceuticals LTD based in Bangladesh. The National Drug Code (NDC) for the medication is 76385-123-01, and it comes in a container with 100 tablets.*
FDA Label Image

750 mg 100 Count Bottle Label (750mg Container)

750 mg 100 Count Bottle Label (750mg Container)
This is a description of a medication called Methocarbamol Tablets USP. It contains 750 mg of Methocarbamol per tablet and the recommended dosage is two tablets three times daily. This information is accompanied by a note to refer to the descriptive literature provided. The medication should be stored in a room with a controlled temperature between 20°C and 25°C (68°F and 77°F) and dispensed in a tight container. The tablets are distributed by Bayshore Pharmaceuticals LLC and have an NDC code of 76385-124-01. The tablets have been manufactured by BEXIMCO PHARMACEUTICALS LTD, located at 126, Kathaldia, Tongi, Gazipur, 1711, Bangladesh.*
FDA Label Image

Structure (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.